Comprehensive Transplant Panel

What is a Comprehensive Transplant Panel?

Comprehensive transplant panel is a molecular diagnostic test designed to detect bacterial, viral, and fungal infections, along with antimicrobial resistance (AMR) genes, in transplant recipients. Utilising multiplex RT-PCR technology, this test rapidly identifies opportunistic pathogens such as CMV, EBV, Candida species, and multidrug-resistant bacteria, which pose a significant risk to immunosuppressed patients. By enabling early infection detection and targeted antimicrobial therapy, the comprehensive transplant panel enhances post-transplant monitoring, reduces complications, and improves long-term graft survival.

Pathogen Coverage in the Comprehensive Transplant Panel

CategoryPathogens Detected
Gram-Positive BacteriaStaphylococcus spp, Staphylococcus aureus, Streptococcus spp, Streptococcus pneumoniae, Enterococcus faecium, Enterococcus faecalis, Listeria monocytogenes.
Gram-Negative BacteriaNeisseria meningitidis, Haemophilus influenzae, Pseudomonas spp, Pseudomonas aeruginosa, Klebsiella pneumoniae, Klebsiella oxytoca, Acinetobacter baumannii, Stenotrophomonas maltophilia, Escherichia coli, Enterobacteriaceae.
Antimicrobial Resistance (AMR) GenesVanA (Vancomycin resistance), VanB (Vancomycin resistance), OXA-48 (Carbapenem resistance), KPC (Carbapenem resistance), NDM (Carbapenem resistance), VIM (Carbapenem resistance), IMP (Carbapenem resistance), mecA/mecC (Methicillin resistance).
FungiCandida krusei, Candida glabrata, Candida albicans, Candida parapsilosis, Candida tropicalis.
VirusesEnterovirus; Epstein-Barr virus (EBV); Herpes Simplex virus 1 (HSV-1); Herpes Simplex virus 2 (HSV-2); Human Adenovirus ;Human Cytomegalovirus (CMV) Human Herpesvirus 6 (HH6); Human Herpesvirus 7 (HH7); Human Parechovirus; Human Parvovirus B-19; Varicella Zoster virus (VZV); JC virus; BK virus.

When is the Comprehensive Transplant Panel Recommended?

  • Post-Transplant Monitoring – Detects early infections and antimicrobial resistance genes, ensuring timely intervention.
  • Essential for Solid Organ & Stem Cell Transplants – Recommended for kidney, liver, heart, lung, and hematopoietic stem cell transplant patients.
  • Improves Long-Term Transplant Success – Helps reduce complications, enhance graft survival, and prevent life-threatening infections.

Specifications

  • Test Code: MGM3206
  • Methodology: Multiplex RT-PCR
  • Turnaround Time: 2 working days
  • Specimen Type: Whole Blood
  • Container : EDTA Tube
  • Transportation Temperature: 2-8°C
  • Volume Requirement: 3ml
  • Storage Conditions: Samples should be transported within 24 hours of collection.
Human DNA structure highlighting MedGenome genetic testing and DNA test in India

Diseases & Disorders Detected by the Comprehensive Transplant Panel Test

Key Highlights of MedGenome's Comprehensive Transplant Panel

Comprehensive Infection Screening

Detects bacterial, viral, and fungal infections, along with antimicrobial resistance (AMR) genes, ensuring early identification of post-transplant complications.

Fast Turnaround Time for Timely Intervention

Provides results within 2 working days, allowing for quick clinical decision-making and personalised patient care.

Trusted by 24,000+ Clinicians

MedGenome is trusted and recommended by 24,000+ clinicians and 8,000+ hospitals across India and South Asia.

What Is a Comprehensive Transplant Panel?

Comprehensive transplant panel is a specialised test designed to check for infections and antimicrobial resistance genes in patients undergoing transplants. Since transplant patients have weakened immune systems, they are at higher risk of bacterial, viral, and fungal infections. This test helps doctors detect infections early, ensuring the right treatment is given before complications arise. By identifying potential infections and drug-resistant pathogens, the test helps improve transplant success rates and patient safety.

MedGenome scientist conducting genetic testing and DNA test services in India

How Does the Comprehensive Transplant Panel Work?

Comprehensive transplant panel works by analysing a patient’s sample to detect the presence of bacteria, viruses, and fungi that can cause infections after a transplant. It also checks for antimicrobial resistance (AMR) genes, which help doctors determine if certain infections are resistant to antibiotics. The test uses advanced molecular technology to quickly and accurately identify infections, allowing for early medical intervention to protect the transplanted organ and the overall health of the patient.

How Is the Comprehensive Transplant Panel Test Done?

MedGenome clinician reviewing patient records to support genetic testing and DNA test in India

Why Is a Comprehensive Transplant Panel Important?

Transplant patients have weakened immune systems due to medications that prevent organ rejection. This makes them more vulnerable to severe infections. Comprehensive transplant panel is important because:

  • It quickly detects infections that could compromise the transplant.
  • It helps doctors choose the right medications by identifying antimicrobial resistance genes.
  • It prevents delayed diagnosis, which can lead to serious complications or transplant failure.
  • It improves post-transplant monitoring, ensuring better long-term outcomes for patients.

Who Should Consider a Comprehensive Transplant Panel?

MedGenome diagnostic imaging supporting advanced genetic testing and DNA test services in India

What Do Comprehensive Transplant Panel Test Results Indicate?

The test results provide valuable insights into the patient’s health:

  • Positive for infection – This means a bacterial, viral, or fungal infection has been detected. Doctors will decide on appropriate treatment based on the pathogen identified.
  • Presence of antimicrobial resistance genes – If resistance genes are found, it means some antibiotics may not work, and an alternative treatment will be needed.
  • Negative for infection – No infections were detected, meaning the patient is not currently at risk from a transplant-related infection.

Can a Comprehensive Transplant Panel Predict Transplant Rejection?

Why Choose MedGenome for Comprehensive Transplant Panel Testing?

Get Genetic Counselling by Our Experts

Connect with Our Experts

    MedGenome Patient Stories

    MedGenome in the News

    September 12, 2023 5 mins read

    NIPT for Twins: What You Should Know?

    December 30, 2021 5 mins read

    Unlocking Insights: Genetic Tests Every Woman Should Consider

    August 21, 2019 5 mins read

    A new technology for eradicating TB – MedGenome Labs – Mathrubhumi

    Please share your details to get
    in touch with our experts.